Novavax (NVAX) Selling, General & Administrative (2010 - 2026)
Novavax (NVAX) recorded Selling, General & Administrative of $26.67 million in Q2 2026, down 38.9% from $43.61 million a year earlier and down 7.3% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a TTM basis, Novavax's Selling, General & Administrative came in at $121.22 million as of Jun 30, 2026, down 49.7% year-over-year; for FY2025, it came in at $157.48 million, down 53.3% from FY2024.
- Annual Selling, General & Administrative has declined for three straight years, though with a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $337.19 million in FY2024 (-28.1%), $468.95 million in FY2023 (-4.0%), $488.69 million in FY2022 (+63.8%) and $298.36 million in FY2021 (+105.4%).
- The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q2 2020.
- On a year-over-year basis, Selling, General & Administrative has declined for eight consecutive quarters, with an average decline of 47.0% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 92.0% in Q4 2022, against a decline of 56.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.78 million (Q1 2026), $34.12 million (Q4 2025) and $31.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn | 23.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.65 Mn |
| Jun 30, 2026 | 26.67 Mn |
| Mar 31, 2026 | 28.78 Mn |
| Dec 31, 2025 | 34.12 Mn |
| Sep 30, 2025 | 31.66 Mn |
| Jun 30, 2025 | 43.61 Mn |
| Mar 31, 2025 | 48.09 Mn |
| Dec 31, 2024 | 78.34 Mn |
| Sep 30, 2024 | 70.75 Mn |
| Jun 30, 2024 | 101.30 Mn |
| Mar 31, 2024 | 86.80 Mn |
| Dec 31, 2023 | 155.24 Mn |
| Sep 30, 2023 | 107.46 Mn |
| Jun 30, 2023 | 93.72 Mn |
| Mar 31, 2023 | 112.53 Mn |
| Dec 31, 2022 | 161.66 Mn |
| Sep 30, 2022 | 122.88 Mn |
| Jun 30, 2022 | 108.16 Mn |
| Mar 31, 2022 | 95.99 Mn |
| Dec 31, 2021 | 84.21 Mn |
API Access
Novavax Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();